# PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders

> **NCT04353986** · PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 24 (estimated)

## Conditions studied

- HCV Infection
- Beta Thalassemia Major

## Interventions

- **DRUG:** Sofosbuvir and Ledipasvir

## Key facts

- **NCT ID:** NCT04353986
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-11
- **Primary completion:** 2023-04
- **Final completion:** 2023-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353986, "PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04353986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*